Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Micronet's spinal cord lead:

This article was originally published in Clinica

Executive Summary

Micronet Medical has received US FDA 510(k) approval for what it claims is the smallest diameter neurostimulation lead on the market. The Axxess lead measures just 0.83mm in diameter and is designed for use with a spinal cord stimulation system for helping to manage chronic, intractable pain of the trunk and limbs. The market for treating pain via spinal stimulation was $200 million in 1999, and is expected to grow to over $400 million by 2003, says St Paul, Minnesota-based Micronet.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT072610

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel